The DOI matches its Crossref record; 64 of the 68 references it cites were found in a registry or an index.
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Abstract
The anatomical distribution and density of cannabinoid receptors in the human brain was studied in one fetal (33 weeks gestation), two neonatal (aged three to six months) and eight adult (aged 21-81 years) human cases using quantitative receptor autoradiography following in vitro labelling of sections with the synthetic cannabinoid agonist [3H]CP55,940. Cannabinoid receptors were distributed in a heterogeneous fashion throughout the adult human brain and spinal cord. The allocortex contained very high concentrations of cannabinoid receptor binding sites in the dentate gyrus, Ammons's horn and subiculum of the hippocampal formation; high concentrations of receptors were also present in the entorhinal cortex and amygdaloid complex. Cannabinoid receptor binding sites were also present throughout all regions of the neocortex, where they showed a marked variation in density between the primary, secondary and associational cortical regions: the greatest densities of receptors were present in the associational cortical regions of the frontal and limbic lobes, with moderate densities in the secondary sensory and motor cortical regions, and with the lowest densities of receptors in the primary sensory and motor cortical regions. Relatively high concentrations of cannabinoid receptors were consistently seen in cortical regions of the left (dominant) hemisphere, known to be associated with verbal language functions. In all of the cortical regions, the pattern and density of receptor labelling followed the neocortical laminar organization, with the greatest density of receptors localized in two discrete bands--a clearly delineated narrow superficial band which coincided with lamina I and a deeper broader, conspicuous band of labelling which corresponded to laminae V and VI. Labelling in the intervening cortical laminae (II-IV) showed lower densities, with a well delineated narrow band of label in the middle of laminae IV in the associational cortical regions. The thalamus showed a distinctive heterogeneous distribution of cannabinoid receptors, with the highest concentration of receptors localized in the mediodorsal nucleus, anterior nuclear complex, and in the midline and intralaminar complex of nuclei, i.e. in thalamic nuclei which have connectional affiliations with the associational cortical areas. The basal ganglia showed a distinctive heterogeneous pattern of receptor binding, with the very highest concentrations in the globus pallidus internus, moderate concentrations in the globus pallidus externus and ventral pallidum, and moderately low levels of binding throughout the striatal complex. In the midbrain, some of the highest levels of cannabinoid receptor binding sites in the human brain were present in the substantia nigra pars reticulata, with very low levels of labelling in all other midbrain areas. The highest densities of cannabinoid receptor binding in the hindbrain were localized in the molecular layer of the cerebellar cortex and the dorsal motor nucleus of the vagus, with moderate densities of receptors in the nucleus of the solitary tract. The spinal cord showed very low levels of receptor binding. Studies on the distribution of cannabinoid receptors in the fetal and neonatal human brain showed similar patterns of receptor distribution to that observed in the adult human brain, except that the density of receptor binding was generally markedly higher, especially in the basal ganglia and substantia nigra. The pattern of cannabinoid receptor labelling in the striatum showed a striking patchy pattern of organization which was especially conspicuous in the fetal brain. These results show that cannabinoid receptor binding sites in the human brain are localized mainly in: forebrain areas associated with higher cognitive functions; forebrain, midbrain and hindbrain areas associated with the control of movement; and in hindbrain areas associated with the control of motor and sensory functions of the autonomic nervous system. (AB
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CB1 receptors are the most abundant G-protein-coupled receptors in the central nervous system12, 13”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [12]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Jones, E. G. (1985) · Springer eBooks · doi:10.1007/978-1-4615-1749-8 · Cited by 1,164
Graybiel, A. M., & Ragsdale, C. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5723 · Cited by 784
Laminar Organization of Thalamic Projections to the Rat Neocortex
Herkenham, M. A. (1980) · Science · doi:10.1126/science.7352263 · Cited by 595
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500
Research works printed but not linked: 9
- Bidaut-Russell, 1989, Opioid and cannabinoid analgetics both inhibit cyclic AMP production in the rat striatum, Adv. Biosci., 75, 165
- Campbell, 1986, Delta-9-tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat detate gyrus, J. Pharmac. exp. Ther., 239, 941
- Chen, 1993, Transient concentration of cannabinoid receptors in the cortex subplate zone during kitten post-natal development, Soc. Neurosci. Abstr., 19, 305
- Devane, 1988, Determination and characterisation of a cannabinoid receptor in rat brain, Molec. Pharmac., 34, 605
- Dewey, 1972, The effects of chronic administration of trans-delta-9-tetrahydorcannibinol on behaviour and the cardiovascular system of dogs, Archs int. Pharmacodyn. Thér., 198, 118
- Edery, 1972, Structure activity relationships in the tetrahydrocanabinol species, Arzneimittel-Forshch., 22, 1995
- Howlett, 1985, Cannabinoid inhibition of adenylate cyclase. Biochemistry of response in neuroblasta cell membrane, Molec. Pharmac., 27, 429
- Howlett, 1986, Involvement of Gi in the inhibition of adenylate cyclase by cannabinoid drugs, Molec. Pharmac., 29, 307
- Mendelson, 1976, Operant acquisition of marijuana by men, J. Pharmac. exp. Ther., 198, 42
Cited by
Sorted by citations
Items 101–200 of 1,000
The endocannabinoid system as a target for the treatment of neurodegenerative disease
Scotter, E. L., Abood, M. E., & Glass, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00735.x · Cited by 188
Self-citationEndocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 188
Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia
Newell, K. A., Deng, C., & Huang, X. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0503-x · Cited by 179
Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity
Gruber, S. A., Dahlgren, M. K., Sagar, K. A., Gönenç, A., & Lukas, S. E. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3326-z · Cited by 177
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S., & Mackie, K. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 187
Effects of prenatal cigarette and marijuana exposure on drug use among offspring
Porath, A. J., & Fried, P. A. (2005) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.12.003 · Cited by 178
Evolutionary origins of the endocannabinoid system
McPartland, J. M., Matias, I., Marzo, V. D., & Glass, M. (2006) · Gene · doi:10.1016/j.gene.2005.11.004 · Cited by 176
Self-citationEffects of prenatal marijuana on visuospatial working memory: An fMRI study in young adults
Smith, A., Fried, P. A., Hogan, M. J., & Cameron, I. G. M. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2005.12.008 · Cited by 181
Prenatal cannabis exposure and infant outcomes: Overview of studies
Huizink, A. C. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.014 · Cited by 178
The genetic epidemiology of substance use disorder: A review
Prom‐Wormley, E. C., Ebejer, J. L., Dick, D. M., & Bowers, M. S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.06.040 · Cited by 185
Review: The neuropathology of drug abuse
Büttner, A. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01131.x · Cited by 172
Cannabinoids and prefrontal cortical function: Insights from preclinical studies
Egerton, A., Allison, C., Brett, R. R., & Pratt, J. A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.12.002 · Cited by 177
Cheetham, A., Allen, N. B., Whittle, S., Simmons, J. G., Yücel, M., & Lubman, D. I. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.029 · Cited by 176
Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity
de Fonseca, F. R., del Arco, I., Martín-Calderón, J. L., Gorriti, M. Á., & Navarro, M. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0217 · Cited by 167
Effects of prenatal marijuana on response inhibition: an fMRI study of young adults
Smith, A., Fried, P. A., Hogan, M. J., & Cameron, I. G. M. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.04.004 · Cited by 166
Benito, C., Kim, W.-K., Chavarría, I., Hillard, C. J., Mackie, K., Tolón, R. M., Williams, K., & Romero, J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3923-04.2005 · Cited by 164
Lower circulating endocannabinoid levels in children with autism spectrum disorder
Aran, A. A., Eylon, M., Harel, M., Polianski, L., Nemirovski, A., Tepper, S., Schnapp, A., Cassuto, H., Wattad, N., & Tam, J. (2019) · Molecular Autism · doi:10.1186/s13229-019-0256-6 · Cited by 164
Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility
du Plessis, S. S., Agarwal, A. K., & Syriac, A. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0553-8 · Cited by 171
McPartland, J. M., Guy, G. W., & Marzo, V. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089566 · Cited by 168
One-Stop Microfluidic Assembly of Human Brain Organoids To Model Prenatal Cannabis Exposure
Ao, Z., Cai, H., Havert, D., Wu, Z., Gong, Z., Beggs, J. M., Mackie, K., & Guo, F. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00205 · Cited by 162
Cannabis and endogenous cannabinoid systems
Childers, S. R., & Breivogel, C. S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00075-1 · Cited by 157
Ferrer, B., Asbrock, N., Kathuria, S., Piomelli, D., & Giuffrida, A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02896.x · Cited by 155
Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain
Wang, X., Dow-Edwards, D. L., Keller, É., & Hurd, Y. L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00020-4 · Cited by 159
Trajectory of adolescent cannabis use on addiction vulnerability
Hurd, Y. L., Michaelides, M., Miller, M. L., & Jutras‐Aswad, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.028 · Cited by 160
Endogenous cannabinoids and appetite
Kirkham, T. C., & Williams, C. M. (2001) · Nutrition Research Reviews · doi:10.1079/095442201108729141 · Cited by 157
Expression of functional cannabinoid CB 2 receptor in VTA dopamine neurons in rats
Zhang, H., Gao, M., Shen, H., Bi, G., Yang, H., Liu, Q., Wu, J., Gardner, E. L., Bonci, A., & Xi, Z. (2016) · Addiction Biology · doi:10.1111/adb.12367 · Cited by 156
Bhattacharyya, S., Wilson, R., Appiah-Kusi, E., O'Neill, A., Brammer, M., Perez, J., Murray, R., Allen, P., Bossong, M., & McGuire, P. (2018) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2018.2309 · Cited by 134
The endocannabinoid system and psychiatric disorders
Parolaro, D., Realini, N., Viganò, D., Guidali, C., & Rubino, T. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.018 · Cited by 151
Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward
Volkow, N. D., Hampson, A. J., & Baler, R. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104615 · Cited by 159
PTSD: from neurobiology to pharmacological treatments
Kelmendi, B., Adams, T., Yarnell, S. C., Southwick, S., Abdallah, C., & Krystal, J. (2016) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v7.31858 · Cited by 136
[18 F ] MK ‐9470 PET measurement of cannabinoid CB 1 receptor availability in chronic cannabis users
Ceccarini, J., Kuepper, R., Kemels, D., van Os, J., Henquet, C., & Laere, K. V. (2013) · Addiction Biology · doi:10.1111/adb.12116 · Cited by 149
THC and CBD: Similarities and differences between siblings
Stella, N. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.022 · Cited by 165
Griffin, G., Wray, E. J., Tao, Q., McAllister, S. D., Rorrer, W. K., Aung, M. M., Martin, B. R., & Abood, M. E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00402-1 · Cited by 154
Dubreucq, S., Matias, I., Cardinal, P., Häring, M., Lutz, B., Marsicano, G., & Chaouloff, F. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.36 · Cited by 158
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
More, S. V., & Choi, D. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0012-0 · Cited by 148
Burggren, A. C., Shirazi, A., Ginder, N., & London, E. D. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1634086 · Cited by 144
Marroun, H. E., Tiemeier, H. W., Franken, I. H. A., Jaddoe, V. W. V., van der Lugt, A., Verhulst, F. C., Lahey, B. B., & White, T. J. H. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.024 · Cited by 152
Hirvonen, J., Zanotti‐Fregonara, P., Umhau, J. C., George, D. T., Rallis-Frutos, D., Lyoo, C. H., Li, C., Hines, C. S., Sun, H., Terry, G. E., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.100 · Cited by 144
Endocannabinoid System and Synaptic Plasticity: Implications for Emotional Responses
Viveros, M., Marco, E. M., Llorente, R., & López‐Gallardo, M. (2007) · Neural Plasticity · doi:10.1155/2007/52908 · Cited by 151
A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain
Ong, W.-Y., & Mackie, K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00025-1 · Cited by 145
Brain Neuroimaging in Cannabis Use: A Review
Quickfall, J., & Crockford, D. N. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.3.318 · Cited by 143
Van Laere, K., Goffin, K., Casteels, C., Dupont, P., Mortelmans, L., de Hoon, J., & Bormans, G. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.053 · Cited by 142
Normandin, M. D., Zheng, M., Lin, K., Mason, N. S., Lin, S.-F., Ropchan, J. R., Labaree, D. C., Henry, S. E., Williams, W. A., Carson, R. E., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.46 · Cited by 145
Gender effects on amygdala morphometry in adolescent marijuana users
McQueeny, T. M., Padula, C. B., Price, J. S., Lisdahl, K. M., Logan, P., & Tapert, S. F. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.031 · Cited by 145
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Khajehali, E., Malone, D. T., Glass, M., Sexton, P. M., Christopoulos, A., & Leach, K. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099192 · Cited by 146
Self-citationFunctional CB2 type cannabinoid receptors at CNS synapses
Morgan, N. H., Stanford, I. M., & Woodhall, G. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.017 · Cited by 146
Marco, E. M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00063 · Cited by 139
Hermann, D., Sartorius, A., Welzel, H., Walter, S., Skopp, G., Ende, G., & Mann, K. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.027 · Cited by 135
Autoradiographic Study of Pre- and Postnatal Distribution of Cannabinoid Receptors in Human Brain
Biegon, A. R., & Kerman, I. A. (2001) · NeuroImage · doi:10.1006/nimg.2001.0939 · Cited by 138
Molecular biology of cannabinoid receptors
Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 138
Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance
González, R. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9036-8 · Cited by 140
Villares, J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.012 · Cited by 134
Amygdala activity contributes to the dissociative effect of cannabis on pain perception
Lee, M., Ploner, M., Wiech, K., Bingel, U., Wanigasekera, V., Brooks, J. C. W., Menon, D. K., & Tracey, I. (2012) · Pain · doi:10.1016/j.pain.2012.09.017 · Cited by 136
McLaughlin, R. J., Hill, M. N., & Gorzalka, B. B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.006 · Cited by 142
Harrold, J. A., Elliott, J. C., King, P., Widdowson, P. S., & Williams, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03245-6 · Cited by 136
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior
Szutorisz, H., & Hurd, Y. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.011 · Cited by 131
Brain Cannabinoid Systems as Targets for the Therapy of Neurological Disorders
Consroe, P. F. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0220 · Cited by 133
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Chye, Y., Christensen, E., Solowij, N., & Yücel, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00063 · Cited by 132
Targeting dopamine D2 and cannabinoid‐1 (CB1) receptors in rat nucleus accumbens
Pickel, V. M., Chan, J., Kearn, C. S., & Mackie, K. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20881 · Cited by 128
Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
Szabó, B., Wallmichrath, I., Mathonia, P., & Pfreundtner, C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00036-1 · Cited by 128
Vinod, K. Y., Arango, V., Xie, S., Kassir, S. A., Mann, J. J., Cooper, T. B., & Hungund, B. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.033 · Cited by 127
Suárez, J., Bermúdez‐Silva, F. J., Mackie, K., Ledent, C. A., Zimmer, A., Cravatt, B. F., & de Fonseca, F. R. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21774 · Cited by 126
The endocannabinoid system is modulated in response to spinal cord injury in rats
García‐Ovejero, D., Arévalo‐Martín, Á., Petrosino, S., Docagne, F., Hagen, C., Bisogno, T., Watanabe, M., Guaza, C., Marzo, V. D., & Molina‐Holgado, E. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.015 · Cited by 128
Lorenzetti, V., Chye, Y., Silva, P., Solowij, N., & Roberts, C. A. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00979-1 · Cited by 125
Endocannabinoid signaling and food addiction
D’Addario, C., Bonaventura, M. V. M. D., Pucci, M., Romano, A., Gaetani, S., Ciccocioppo, R., Cifani, C., & Maccarrone, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.08.008 · Cited by 124
Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
Grimsey, N. L., Goodfellow, C. E., Scotter, E. L., Dowie, M. J., Glass, M., & Graham, E. S. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.02.014 · Cited by 123
Self-citationNeuroimaging of children following prenatal drug exposure
Derauf, C., Kekatpure, M., Neyzi, N., Lester, B., & Kosofsky, B. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.03.001 · Cited by 122
Organization of Brainstem Nuclei
Paxinos, G., Huang, X., Şengül, G., & WATSON, C. R. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374236-0.10008-2 · Cited by 122
Sigma receptors [σRs]: biology in normal and diseased states
Rousseaux, C. G., & Greene, S. F. (2015) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2015.1015737 · Cited by 123
Beyond Cannabis: Plants and the Endocannabinoid System
Russo, E. B. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.04.005 · Cited by 121
Dellazizzo, L., Potvin, S., Giguère, S., & Dumais, A. (2022) · Addiction · doi:10.1111/add.15764 · Cited by 120
Salio, C., Fischer, J., Franzoni, M. F., & Conrath, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00584-x · Cited by 123
Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 119
Endocannabinoids and neurodegenerative diseases
Micale, V., Mazzola, C., & Drago, F. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.008 · Cited by 119
Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex
Long, L. E., Lind, J., Webster, M. J., & Weickert, C. S. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-87 · Cited by 119
Griffin, G., Atkinson, P. J., Showalter, V. M., Martin, B. R., & Abood, M. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37418-x · Cited by 118
Urigüen, L., García-Fuster, M. J., Callado, L. F., Morentín, B., Harpe, R. L., Casadó, V., Lluís, C., Franco, R., Garcı́a-Sevilla, J. A., & Meana, J. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1608-2 · Cited by 115
Neurobiological signatures associated with alcohol and drug use in the human adolescent brain
Silveri, M. M., Dager, A. D., Cohen‐Gilbert, J. E., & Sneider, J. T. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.042 · Cited by 124
Vinod, K. Y., Kassir, S. A., Hungund, B. L., Cooper, T. B., Mann, J. J., & Arango, V. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.11.013 · Cited by 114
Cannabidiol as a potential treatment for psychosis
Davies, C., & Bhattacharyya, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319881916 · Cited by 121
11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors.
Horti, A. G., Fan, H. S., Kuwabara, H., Hilton, J., Ravert, H. T., Holt, D. P., Alexander, M., Kumar, A., Rahmim, A., Scheffel, U., et al. (2006) · PubMed · Cited by 113
Noland, J. S., Singer, L. T., Arendt, R. E., Minnes, S., Short, E. J., & Bearer, C. F. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000060525.10536.f6 · Cited by 113
Jaggar, S., Scott, H. C., & Rice, A. S. C. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/83.3.442 · Cited by 113
Basavarajappa, B. S. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866910 · Cited by 115
Institute of Medicine (1999) · National Academies Press eBooks · doi:10.17226/6376 · Cited by 114
Endocannabinoid Signaling in the Control of Social Behavior
Don, W., Allsop, S. A., Tye, K. M., & Piomelli, D. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.005 · Cited by 120
Role of endocannabinoids in brain development
Fernández‐Ruíz, J., Berrendero, F., Hernández, M., Romero, J., & Ramos, J. A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00295-7 · Cited by 111
Cawston, E. E., Redmond, W. J., Breen, C. M., Grimsey, N. L., Connor, M. A., & Glass, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12329 · Cited by 110
Self-citationHuestis, M. A., Mazzoni, I. E., & Rabin, O. (2011) · Sports Medicine · doi:10.2165/11591430-000000000-00000 · Cited by 110
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110
Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse
Wallmichrath, I., & Szabó, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00109-4 · Cited by 110
Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders
Kaul, M., Zee, P. C., & Sahni, A. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01013-w · Cited by 116
Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 110
Lever, I. J., & Rice, A. S. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_10 · Cited by 108
The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats
Schneider, M., & Koch, M. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200202000-00003 · Cited by 108
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis
Nia, A. B., Medrano, B., Perkel, C., GALYNKER, I. I., & Hurd, Y. L. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116658990 · Cited by 107
Expression of cannabinoid CB 1 receptor mRNA in basal ganglia of normal and parkinsonian human brain
Hurley, M. J., Mash, D. C., & Jenner, P. G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0033-7 · Cited by 109
The role of the CB1 receptor in the regulation of sleep
Murillo‐Rodríguez, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.04.008 · Cited by 115
Terry, G. E., Liow, J., Zoghbi, S. S., Hirvonen, J., Farris, A. G., Lerner, A., Tauscher, J. T., Schaus, J. M., Phebus, L. A., Felder, C. C., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.059 · Cited by 106
Role of Cannabinoids in Multiple Sclerosis
Zajicek, J., & Apostu, V. I. (2011) · CNS Drugs · doi:10.2165/11539000-000000000-00000 · Cited by 106
Metadata
- Authors
- Glass, M., Faull, R. L. M., & Dragunow, M.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Faull, R.L.M
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1997-02
- Volume
- 77
- Issue
- 2
- Pages
- 299-318
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2037811574
- Cited by
- 1,052
- References
- 68
- Citations by year
- 2026: 28 · 2025: 40 · 2024: 34 · 2023: 39 · 2022: 56 · 2021: 53 · 2020: 52 · 2019: 48 · 2018: 46 · 2017: 49 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 42
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- cannabinoid receptors, human brain, receptor distribution, receptor density, fetal brain, neonatal brain, hippocampal formation, neocortex, cortical laminar organization, thalamus, basal ganglia, midbrain, spinal cord, globus pallidus internus, globus pallidus externus, ventral pallidum, striatum, amygdala, entorhinal cortex, hemispheric lateralization, CP55,940
- MeSH terms
- Adult, Aged, Aged, 80 and over, Autoradiography, Brain, Brain Chemistry, Brain Mapping, Cannabinoids, Coloring Agents, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myelin Sheath, Pregnancy, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review